Skip to search formSkip to main contentSkip to account menu

European Treatment Outcome Study Score

Known as: EUTOS, European Treatment Outcome Study (EUTOS) Score 
A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Introduction In a developing country like Algeria, such expensive therapy is not available. Alternative approaches are needed to… 
2017
2017
Smoking is suspected to not only be a risk factor for chronic myeloid leukemia but an adverse prognostic factor for the disease… 
2015
2015
The tyrosine kinase inhibitor (TKI) imatinib has revolutionized the management of chronic myeloid leukaemia (CML). However… 
Review
2015
Review
2015
Tyrosine kinase inhibitor (TKI) treatment has dramatically improved the outcome of chronic myelogenous leukemia in the chronic… 
2014
2014
The introduction of tyrosine kinase inhibitors has dramatically improved outcomes for many patients with chronic myeloid leukemia… 
2012
2012
Abstract 2794 Background The main difference of recently developed new prognostic classification, EUTOS score, from the… 
Highly Cited
2011
Highly Cited
2011
TO THEEDITOR: In 1984, Sokal et al 1 developed a scoring system to predict the outcome of patients with chronic myeloid leukemia… 
2011
2011
Abstract 3762 Introduction: The EUTOS Score was developed and validated as a prognostic tool for the achievement of complete…